Oxford Cannabinoid Technologies Holdings Plc (LON:OCTP – Get Free Report) shares fell 66.6% during trading on Wednesday . The company traded as low as GBX 0.05 ($0.00) and last traded at GBX 0.12 ($0.00). 33,863,473 shares changed hands during trading, an increase of 515% from the average session volume of 5,502,056 shares. The stock had previously closed at GBX 0.35 ($0.00).
Oxford Cannabinoid Technologies Trading Down 7.7 %
The company has a fifty day moving average price of GBX 0.39 and a two-hundred day moving average price of GBX 0.57. The firm has a market capitalization of £1.56 million, a PE ratio of -53.10 and a beta of 0.79.
About Oxford Cannabinoid Technologies
Oxford Cannabinoid Technologies Holdings Plc, a pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based prescription medicines. Its lead drug candidate consists of OCT461201, an CB2 receptor, that is in phase I clinical trial for use in the treatment of chemotherapy-induced peripheral neuropathy and irritable bowel syndrome (IBS), as well as in neuropathic and visceral pain conditions.
See Also
- Five stocks we like better than Oxford Cannabinoid Technologies
- Best Aerospace Stocks Investing
- Roblox: The Bottom Just Fell Out of the Metaverse
- How to Invest in Blue Chip Stocks
- Airbnb Stock Plummets After Earnings, But is It a Buy?
- What is a Secondary Public Offering? What Investors Need to Know
- Uber’s Earnings Drop Is Investors Opportunity
Receive News & Ratings for Oxford Cannabinoid Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Cannabinoid Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
